Urquhart R A, Ford W R, Broadley K J
Department of Pharmacology, Welsh School of Pharmacy, University of Wales College of Cardiff.
J Cardiovasc Pharmacol. 1993 Feb;21(2):279-88. doi: 10.1097/00005344-199302000-00014.
The negative inotropic responses of guinea pig isolated left atria to the P1-receptor agonists adenosine and L-N6-phenylisopropyladenosine (L-PIA), the muscarinic receptor agonist carbachol, and the potassium channel activator cromakalim were examined. The potassium channel blocker 4-aminopyridine (4-AP, 10 mM) decreased the concentration-response curve for L-N-6-phenylisopropyladenosine (L-PIA) so that the maximum reduction in atrial tension was significantly reduced from 77.8 to 61.9%. The concentration-response curve for the negative inotropic response to carbachol was displaced to the right by a substantially greater amount (521-fold), partly due to the muscarinic receptor blocking activity of 4-AP. The response to a single submaximum dose of L-PIA (520 nM) was slow in onset and monophasic, whereas adenosine induced a rapid reduction in tension followed by a gradual return toward the resting level. In the presence of 4-AP (10 mM), the peak response to L-PIA was significantly reduced from a 59.7 to 31.0% inhibition of tension. In addition, the rate of development of the response was significantly slowed. The peak inhibition of tension by adenosine (112 microM) (60.0%) was also significantly reduced to 37.4% in the presence of 4-AP (10 mM). Furthermore, there was no rapid decrease in tension but a gradual decrease to a peak effect which was no different from that in the absence of 4-AP. These results suggest that the P1-receptor agonists exert negative inotropy through a K+ channel-dependent component which is blocked by 4-AP and a slower-onset K+ channel-independent component. The potassium channel blocker, bromobenzoylmethyladamantylamine (BMA 100 microM) also shifted (11-fold) the concentration-response curve for the negative inotropic response to adenosine, and to a lesser extent that to cromakalim (2.1-fold) and carbachol. Glibenclamide (0.3, 3, and 30 microM), a selective antagonist of ATP-regulated potassium channels, was a potent antagonist of the negative inotropic responses to cromakalim. However, 30 microM failed to antagonize the responses to L-PIA, adenosine, or carbachol, indicating that they do not mediate their responses through ATP-regulated potassium channels. 4-AP (10 mM) caused a slight shift (2.3-fold) of the concentration-response curve for cromakalim, indicating weak activity against ATP-regulated potassium channels in the left atrium. This study showed that P1-receptor agonists exert negative inotropic responses in guinea pig left atria only in part through activation of potassium channels. These channels differ from the ATP-regulated potassium channels activated by cromakalim.
研究了豚鼠离体左心房对P1受体激动剂腺苷和L-N6-苯异丙基腺苷(L-PIA)、毒蕈碱受体激动剂卡巴胆碱以及钾通道激活剂克罗卡林的负性肌力反应。钾通道阻滞剂4-氨基吡啶(4-AP,10 mM)使L-N-6-苯异丙基腺苷(L-PIA)的浓度-反应曲线降低,使得心房张力的最大降低幅度从77.8%显著降至61.9%。对卡巴胆碱负性肌力反应的浓度-反应曲线向右大幅移位(521倍),部分原因是4-AP的毒蕈碱受体阻断活性。对单次亚最大剂量L-PIA(520 nM)的反应起效缓慢且呈单相性,而腺苷则导致张力迅速降低,随后逐渐恢复至静息水平。在4-AP(10 mM)存在的情况下,L-PIA的峰值反应从张力抑制的59.7%显著降至31.0%。此外,反应的发展速率显著减慢。在4-AP(10 mM)存在的情况下,腺苷(112 microM)引起的张力峰值抑制(60.0%)也显著降至37.4%。此外,张力没有迅速降低,而是逐渐降低至峰值效应,这与不存在4-AP时没有差异。这些结果表明,P1受体激动剂通过一个被4-AP阻断的K+通道依赖性成分和一个起效较慢的K+通道非依赖性成分发挥负性肌力作用。钾通道阻滞剂溴苯甲酰甲基金刚烷胺(BMA 100 microM)也使腺苷负性肌力反应的浓度-反应曲线移位(11倍),对克罗卡林和卡巴胆碱的浓度-反应曲线移位程度较小(2.1倍)。格列本脲(0.3、3和30 microM)是ATP调节钾通道的选择性拮抗剂,是克罗卡林负性肌力反应的有效拮抗剂。然而,30 microM未能拮抗对L-PIA、腺苷或卡巴胆碱的反应,表明它们不是通过ATP调节钾通道介导其反应的。4-AP(10 mM)使克罗卡林的浓度-反应曲线略有移位(2.3倍),表明其对左心房ATP调节钾通道的活性较弱。本研究表明,P1受体激动剂在豚鼠左心房中仅部分通过激活钾通道发挥负性肌力反应。这些通道与克罗卡林激活的ATP调节钾通道不同。